Location: Home
  • search
  • go
  • Relate News
  • 11/15/2019CDE Accepts Lilly's NDA for Verzenio (Abemaciclib)
  • 11/13/2019Thermo Fisher Opens Customer Solution Center in China
  • 11/13/2019China Issues the Provisions for Health Insurance Administration
  • 11/13/2019Pharmaceutical Innovation in the APAC Region
  • 11/13/2019LEO Pharma, HitGen to Develop Novel Class of Derma Drugs
  • 11/13/2019Hua Medicine's Pivotal Phase III Monotherapy Trial of Dorzagliatin
  • 11/13/2019As Trade War Continues, Pharma Companies Prepare for Alternatives
  • 11/11/2019Chi-Med Announces NDA Acceptance for Novel Drug Surufatinib
  • 11/11/2019CDE Extends Deadline for Public Comments on Nine Draft Documents
  • 11/8/2019NDRC Issues the Work Plan for Building Regional Medical Centers
  • 11/8/2019NHC Issues Notice to Establish National and Regional Mental Medicine+C...
  • 11/7/2019Biogen and Samsung Expand Biosimilar Deal to Cover China and More Prod...
  • 11/7/2019Tot Biopharm Raises $75.2M in Hong Kong IPO
  • 11/7/2019Restrictions and Conflicts - Challenges Faced by Pharmaceutical Tradem...
  • 11/7/2019Top Execs from AstraZeneca, Roche, Sanofi and GSK Tout China Investmen...
  • 11/7/2019Sun Pharma, AstraZeneca Enter Licensing Deal to Market Novel Oncology ...
  • 11/7/2019MD Anderson Inks In-licensing Deal with Artios and ShangPharma
  • 11/7/2019NMPA Approves Bio-Thera’s Adalimumab Biosimilar
  • 11/6/2019Jacobson Pharma to Market Vemedia's Excilor Portfolio in China
  • 11/4/2019NMPA Approves the World's First Seaweed-based Alzheimer's Drug
  • 11/1/2019China Issues Opinions for Establishing / Improving Senior Healthcare S...
  • 11/1/2019NMPA and WHO Sign Statement of Intent to Deepen Cooperation
  • 11/1/2019Amgen To Acquire 20.5% Stake In BeiGene to Expand Anticancer Sales in ...
  • 10/31/2019Financial-related Company News in Brief
  • 10/31/2019Listed Chinese MedPharm Cos Report Varied Performance in 3Qs/2019
  • 10/31/2019Recent Executive Moves
  • 10/31/2019SinoMab BioScience Files $223M IPO in Hong Kong
  • 10/31/2019Alphamab Seeks Approval for HK IPO of Upto $350M - Sources
  • 10/31/2019Shanghai's I-Mab Plans $100M Nasdaq IPO
  • 10/31/2019U.S. Mulls Boost of Domestic Pharma Production as Quality and China De...
  • Page:144/372 Total number of articles:11147: [First][<<] [142] [143] [144] [145] [146] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group